Literature DB >> 15546400

Cytokines in cancer immunity and immunotherapy.

Mark J Smyth1, Erika Cretney, Michael H Kershaw, Yoshihiro Hayakawa.   

Abstract

The concept that the immune system recognizes and controls cancer was first postulated over a century ago, and cancer immunity has continued to be vigorously debated and experimentally tested. Mounting evidence in humans and mice supports the involvement of cytokines in tumor initiation, growth, and metastasis. The idea that the immune system detects stressed, transformed, and frankly malignant cells underpins much of the excitement currently surrounding new cytokine therapies in cancer treatment. In this review, we define the contrasting roles that cytokines play in promoting tumor immunity, inflammation, and carcinogenesis. We also discuss the more promising aspects of clinical cytokine use in cancer patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546400     DOI: 10.1111/j.0105-2896.2004.00199.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  123 in total

Review 1.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

2.  Continuous stress disrupts immunostimulatory effects of IL-12.

Authors:  Ben Levi; Marganit Benish; Yael Goldfarb; Liat Sorski; Rivka Melamed; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-01-28       Impact factor: 7.217

3.  Transplantation of β-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma.

Authors:  Dipak K Sarkar; Changqing Zhang; Sengottuvelan Murugan; Madhavi Dokur; Nadka I Boyadjieva; Maria Ortigüela; Kenneth R Reuhl; Sepide Mojtehedzadeh
Journal:  Cancer Res       Date:  2011-08-11       Impact factor: 12.701

4.  Site-specific fibroblasts regulate site-specific inflammatory niche formation in gastric cancer.

Authors:  Anna Abe; Akiko Kawano Nagatsuma; Youichi Higuchi; Yuka Nakamura; Kazuyoshi Yanagihara; Atsushi Ochiai
Journal:  Gastric Cancer       Date:  2015-12-22       Impact factor: 7.370

5.  1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes.

Authors:  Jian Guo; Zhenhua Ma; Qingyong Ma; Zheng Wu; Ping Fan; Xiaojie Zhou; Lulu Chen; Shuang Zhou; David Goltzman; Dengshun Miao; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

6.  CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

Authors:  Kavya Rakhra; Pavan Bachireddy; Tahera Zabuawala; Robert Zeiser; Liwen Xu; Andrew Kopelman; Alice C Fan; Qiwei Yang; Lior Braunstein; Erika Crosby; Sandra Ryeom; Dean W Felsher
Journal:  Cancer Cell       Date:  2010-10-28       Impact factor: 31.743

7.  Changing the natural history of metachronous gastric cancer after H. pylori eradication.

Authors:  David Y Graham; Satoko Matsueda; Akiko Shiotani
Journal:  Jpn J Helicobacter Res       Date:  2015

Review 8.  A cytokine-mediated link between innate immunity, inflammation, and cancer.

Authors:  Wan-Wan Lin; Michael Karin
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.

Authors:  Gabriela Maria Wiedemann; Severin Johannes Jacobi; Michael Chaloupka; Angelina Krächan; Svetlana Hamm; Stefan Strobl; Roland Baumgartner; Simon Rothenfusser; Peter Duewell; Stefan Endres; Sebastian Kobold
Journal:  Oncoimmunology       Date:  2016-05-31       Impact factor: 8.110

10.  IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.

Authors:  M Czystowska; J Han; M J Szczepanski; M Szajnik; K Quadrini; H Brandwein; J W Hadden; K Signorelli; T L Whiteside
Journal:  Cell Death Differ       Date:  2009-01-30       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.